Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew E. Hendifar"'
Autor:
Jose M. Garcia, Richard F. Dunne, Kristen Santiago, Lisa Martin, Morris J. Birnbaum, Jeffrey Crawford, Andrew E. Hendifar, Martin Kochanczyk, Cassadie Moravek, Doris Piccinin, Vincent Picozzi, Eric J. Roeland, Wendy K.D. Selig, Teresa A. Zimmers
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 2, Pp 1418-1425 (2022)
Externí odkaz:
https://doaj.org/article/1ddd00e55eb746dfa77b6814140d5643
Autor:
Jun Gong, Arsen Osipov, Jeremy Lorber, Mourad Tighiouart, Albert K. Kwan, Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Abrahm Levi, Anser Abbas, John Davelaar, Neil Bhowmick, Andrew E. Hendifar
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1392 (2023)
Advanced pancreatic cancer is underscored by progressive therapeutic resistance and a dismal 5-year survival rate of 3%. Preclinical data demonstrated glutamine supplementation, not deprivation, elicited antitumor effects against pancreatic ductal ad
Externí odkaz:
https://doaj.org/article/f0b25285990f44ef9808c8aef61b701a
Autor:
Arjun Gupta, Omar Khalid, Cassadie Moravek, Anica Lamkin, Lynn M. Matrisian, Sudheer Doss, Crystal S. Denlinger, Andrew L. Coveler, Colin D. Weekes, Eric J. Roeland, Andrew E. Hendifar, Ryan D. Nipp
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7152-7161 (2021)
Abstract Background The Pancreatic Cancer Action Network (PanCAN) Patient Registry is an online, pancreatic cancer‐specific, global registry enabling patients to self‐report sociodemographics, disease/management characteristics, and patient‐rep
Externí odkaz:
https://doaj.org/article/8e578e5119c14f258b24d714ce438ede
Autor:
Kenneth H. Yu, Andrew E. Hendifar, Olatunji B. Alese, Amber Draper, Maen Abdelrahim, Ethan Burns, Gazala Khan, Paul Cockrum, Rachel H. Bhak, Catherine Nguyen, Maral DerSarkissian, Mei Sheng Duh, Nathan Bahary
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe NAPOLI-1 trial demonstrated that liposomal irinotecan in combination with fluorouracil (5-FU) and leucovorin (LV) prolonged survival with a manageable safety profile in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) p
Externí odkaz:
https://doaj.org/article/43a57f71459e47a9b5b2ba864581164f
Autor:
Nan Wang, Srinivas Gaddam, Yibin Xie, Anthony G. Christodoulou, Chaowei Wu, Sen Ma, Zhaoyang Fan, Lixia Wang, Simon Lo, Andrew E. Hendifar, Stephen J. Pandol, Debiao Li
Publikováno v:
Frontiers in Oncology. 12
Background and aimsAccurate differentiation of chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC) is an area of unmet clinical need. In this study, a novel Multitasking dynamic contrast enhanced (DCE) magnetic resonance imaging (MR